PharmaCielo (TSXV:PCLO) Accounts Payable & Accrued Expense : C$7.03 Mil (As of Sep. 2023)

View and export this data going back to 2018. Start your Free Trial

What is PharmaCielo Accounts Payable & Accrued Expense?

PharmaCielo's quarterly accounts payable & accrued expense increased from Mar. 2023 (C$6.58 Mil) to Jun. 2023 (C$6.87 Mil) and increased from Jun. 2023 (C$6.87 Mil) to Sep. 2023 (C$7.03 Mil).

PharmaCielo's annual accounts payable & accrued expense declined from Dec. 2020 (C$11.71 Mil) to Dec. 2021 (C$7.73 Mil) and declined from Dec. 2021 (C$7.73 Mil) to Dec. 2022 (C$6.11 Mil).

PharmaCielo Accounts Payable & Accrued Expense Historical Data

The historical data trend for PharmaCielo's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaCielo Accounts Payable & Accrued Expense Chart

PharmaCielo Annual Data

Trend

Aug17

Aug18

Dec19

Dec20

Dec21

Dec22

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

0.02

3.04

11.71

7.73

6.11

PharmaCielo Quarterly Data
	Nov18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															6.30	6.11	6.58	6.87	7.03

PharmaCielo Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

PharmaCielo (TSXV:PCLO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PharmaCielo Ltd (TSXV:PCLO) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

PCLOF:USA

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.pharmacielo.com

PharmaCielo Ltd is a pharma company, with a focus on ethical and sustainable processing and supplying of both THC(tetrahydrocannabinol) and CBD (cannabidiol) medicinal cannabis extracts. The company operates in Canada, Colombia, Italy, and Mexico. It generates the majority of the revenue in the form of the Sale of Cannabis derivative products in Colombia.

Executives

Ian D Atacan

Director, Senior Officer

PharmaCielo (TSXV:PCLO) Headlines

No Headlines